Related references
Note: Only part of the references are listed.Activation of the Ano1 (TMEM16A) chloride channel by calcium is not mediated by calmodulin
Kuai Yu et al.
JOURNAL OF GENERAL PHYSIOLOGY (2014)
STRUCTURE AND FUNCTION OF TMEM16 PROTEINS (ANOCTAMINS)
Nicoletta Pedemonte et al.
PHYSIOLOGICAL REVIEWS (2014)
Role of anoctamins in cancer and apoptosis
Podchanart Wanitchakool et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
The Ca2+-activated Cl- channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis
Zhiqiang Qu et al.
CANCER MEDICINE (2014)
Downregulation of Ca2+-Activated Cl- Channel TMEM16A by the Inhibition of Histone Deacetylase in TMEM16A-Expressing Cancer Cells
Sayo Matsuba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Calmodulin-dependent activation and inactivation of anoctamin calcium-gated chloride channels
Kerstin Vocke et al.
JOURNAL OF GENERAL PHYSIOLOGY (2013)
TMEM16A alternative splicing coordination in breast cancer
Ifeoma Ubby et al.
MOLECULAR CANCER (2013)
Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival
Yong Fang et al.
PLOS ONE (2013)
Dynamic modulation of ANO1/TMEM16A HCO3- permeability by Ca2+/calmodulin
Jinsei Jung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Adrian Britschgi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dual HER2-targeted approaches in HER2-positive breast cancer
Eugene R. Ahn et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Inhibition of Ca2+-activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
Wen Liu et al.
CANCER LETTERS (2012)
TMEM16A Induces MAPK and Contributes Directly to Tumorigenesis and Cancer Progression
Umamaheswar Duvvuri et al.
CANCER RESEARCH (2012)
Downregulation of TMEM16A Calcium-Activated Chloride Channel Contributes to Cerebrovascular Remodeling During Hypertension by Promoting Basilar Smooth Muscle Cell Proliferation
Mi Wang et al.
CIRCULATION (2012)
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition
Wei Zhu et al.
GUT (2012)
Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma
Hana Akpalo et al.
HISTOPATHOLOGY (2012)
11q13 is a susceptibility locus for hormone receptor positive breast cancer
Diether Lambrechts et al.
HUMAN MUTATION (2012)
Enhanced Expression of ANO1 in Head and Neck Squamous Cell Carcinoma Causes Cell Migration and Correlates with Poor Prognosis
Christian Ruiz et al.
PLOS ONE (2012)
Anoctamin 1 (Tmem16A) Ca2+-activated chloride channel stoichiometrically interacts with an ezrin-radixin-moesin network
Patricia Perez-Cornejo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
International Union of Basic and Clinical Pharmacology. LXXXV: Calcium-Activated Chloride Channels
Fen Huang et al.
PHARMACOLOGICAL REVIEWS (2012)
Physiological roles and diseases of tmem16/anoctamin proteins: are they all chloride channels?
Charity Duran et al.
ACTA PHARMACOLOGICA SINICA (2011)
Voltage- and calcium-dependent gating of TMEM16A/Ano1 chloride channels are physically coupled by the first intracellular loop
Qinghuan Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Chloride Channels: Often Enigmatic, Rarely Predictable
Charity Duran et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines
C. Ayoub et al.
BRITISH JOURNAL OF CANCER (2010)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T. Weigel et al.
ENDOCRINE-RELATED CANCER (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Estrogen and progesterone receptors: from molecular structures to clinical targets
Stephan Ellmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels
H. Criss Hartzell et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
An Economic Evaluation of Adjuvant Trastuzumab Therapy in HER2-Positive Early Breast Cancer
Wen Chen et al.
VALUE IN HEALTH (2009)
Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer
Ana Carneiro et al.
BMC CANCER (2008)
Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling
Elona Bicaku et al.
CANCER RESEARCH (2008)
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit
Bjoern Christian Schroeder et al.
CELL (2008)
TMEM16A confers receptor-activated calcium-dependent chloride conductance
Young Duk Yang et al.
NATURE (2008)
TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity
Antonella Caputo et al.
SCIENCE (2008)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
Alan S. Coates et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
M Dowsett et al.
ANNALS OF ONCOLOGY (2006)
Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display
A Carles et al.
ONCOGENE (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status
RB West et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Share Paper
